العربية
Health

Saudi Arabia, UK sign agreement to accelerate access to innovative medical treatments

The Saudi Food and Drug Authority (SFDA) signed a memorandum of understanding (MoU) with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) to advance the evaluation of innovative treatments and facilitate timely patient access to them.

Read the full article at Saudi Gazette

More on this topic